Sat, Nov 22, 2014, 10:38 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • predictor_98456 predictor_98456 Dec 13, 2012 7:22 AM Flag

    Brean Starts SNTA at Buy

    Per etrade.

    Nice!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Synta Pharmaceuticals Corp. (NASDAQ: SNTA) in a research note issued to investors on Thursday. The firm issued a buy rating and a $12.00 target price on the stock.
      Several other analysts have also recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Synta Pharmaceuticals Corp. from $15.00 to $22.00 in a research note to investors on Monday, October 1st. They now have a buy rating on the stock.

      Sentiment: Hold

    • Brean Murray began coverage on shares of Synta Pharmaceuticals Corp. (NASDAQ: SNTA) in a research note issued to investors on Thursday. The firm issued a buy rating and a $12.00 target price on the stock.
      Several other analysts have also recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Synta Pharmaceuticals Corp. from $15.00 to $22.00 in a research note to investors on Monday, October 1st. They now have a buy rating on the stock.

 
SNTA
3.18+0.09(+2.91%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST
Praxair Inc.
NYSEFri, Nov 21, 2014 4:05 PM EST